Ultragenyx Pharmaceutical (RARE) Cash from Investing Activities Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.12% |
| Dec 31, 2025 | -22.32% |
| Sep 30, 2025 | 26.38% |
| Jun 30, 2025 | 23.08% |
| Mar 31, 2025 | 26.67% |
| Dec 31, 2024 | 8.79% |
| Sep 30, 2024 | -40.49% |
| Jun 30, 2024 | 24.88% |
| Mar 31, 2024 | 24.01% |
| Dec 31, 2023 | -28.14% |
| Sep 30, 2023 | 31.74% |
| Jun 30, 2023 | 31.35% |
| Mar 31, 2023 | 28.96% |
| Dec 31, 2022 | -37.92% |
| Sep 30, 2022 | -49.36% |
| Jun 30, 2022 | 41.91% |
| Mar 31, 2022 | -28.61% |
| Dec 31, 2021 | 63.42% |
| Sep 30, 2021 | -22.66% |
| Jun 30, 2021 | -30.05% |
| Mar 31, 2021 | -59.67% |
| Dec 31, 2020 | 37.51% |
| Sep 30, 2020 | 7.80% |
| Jun 30, 2020 | 4.95% |
| Mar 31, 2020 | -87.87% |
| Dec 31, 2019 | 42.87% |
| Sep 30, 2019 | 51.02% |
| Jun 30, 2019 | -16.29% |
| Mar 31, 2019 | -9.12% |
| Dec 31, 2018 | 45.94% |
| Sep 30, 2018 | 86.55% |
| Jun 30, 2018 | -3.92% |
| Mar 31, 2018 | -36.30% |